Medica Coverage Changes for COVID-19 Diagnostic Testing
March 19, 2020
Information about the 2019 novel coronavirus, also known as COVID-19, is now headline news. This new strain of viral respiratory illness was first identified in Wuhan, China, but has since spread to other areas of the world, including the United States. Scientists are working to better understand the virus and answer questions about its severity and duration and how easily it can be transmitted between people.
Coverage for COVID-19 Diagnostic Testing
Medica has announced a coverage change related to the diagnostic testing for COVID-19 that follow guidelines issued through the U.S. Centers for Disease Control (CDC) and state health departments. Medica will waive co-pays, co-insurance and deductibles related to COVID-19 testing for all fully insured group, individual and Medicare members. Self-insured employers will have an opportunity to also waive fees related to the testing of COVID-19. This change is effective immediately.
To help limit the spread of COVID-19, Medica provides coverage for virtual care or telehealth services, often a more convenient way to access health care services from home. When appropriate, members are encouraged to utilize virtual care benefits.
The health and well-being of members is a priority and Medica will continue to monitor the status of COVID-19 and its impact on our members.